Title : Bortezomib limits renal allograft interstitial fibrosis by inhibiting NF-κB/TNF-α/Akt/mTOR/P70S6K/Smurf2 pathway via IκBα protein stabilization.

Pub. Date : 2021 Jan 15

PMID : 33289516






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Bortezomib limits renal allograft interstitial fibrosis by inhibiting NF-kappaB/TNF-alpha/Akt/mTOR/P70S6K/Smurf2 pathway via IkappaBalpha protein stabilization. Bortezomib nuclear factor kappa B subunit 1 Homo sapiens
2 In addition to blocking Akt/mammalian target of rapamycin (mTOR)/p70S6 kinase/Smurf2 signaling, bortezomib"s effect on the epithelial-mesenchymal transition was associated with inhibition of nuclear factor kappa B (NF-kappaB) pathway by stabilizing inhibitor of NF-kappaB. Bortezomib nuclear factor kappa B subunit 1 Homo sapiens
3 In addition to blocking Akt/mammalian target of rapamycin (mTOR)/p70S6 kinase/Smurf2 signaling, bortezomib"s effect on the epithelial-mesenchymal transition was associated with inhibition of nuclear factor kappa B (NF-kappaB) pathway by stabilizing inhibitor of NF-kappaB. Bortezomib nuclear factor kappa B subunit 1 Homo sapiens
4 In addition to blocking Akt/mammalian target of rapamycin (mTOR)/p70S6 kinase/Smurf2 signaling, bortezomib"s effect on the epithelial-mesenchymal transition was associated with inhibition of nuclear factor kappa B (NF-kappaB) pathway by stabilizing inhibitor of NF-kappaB. Bortezomib nuclear factor kappa B subunit 1 Homo sapiens